256 related articles for article (PubMed ID: 34294762)
21. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).
Amrein M; Li XS; Walter J; Wang Z; Zimmermann T; Strebel I; Honegger U; Leu K; Schäfer I; Twerenbold R; Puelacher C; Glarner N; Nestelberger T; Koechlin L; Ceresa B; Haaf P; Bakula A; Zellweger M; Hazen SL; Mueller C
Clin Res Cardiol; 2022 Jun; 111(6):692-704. PubMed ID: 35220448
[TBL] [Abstract][Full Text] [Related]
22. Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI.
Matsuzawa Y; Nakahashi H; Konishi M; Sato R; Kawashima C; Kikuchi S; Akiyama E; Iwahashi N; Maejima N; Okada K; Ebina T; Hibi K; Kosuge M; Ishigami T; Tamura K; Kimura K
Sci Rep; 2019 Aug; 9(1):11647. PubMed ID: 31406181
[TBL] [Abstract][Full Text] [Related]
23. Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: The Atherosclerosis Risk in Communities Cohort Study.
McEvoy JW; Lazo M; Chen Y; Shen L; Nambi V; Hoogeveen RC; Ballantyne CM; Blumenthal RS; Coresh J; Selvin E
Int J Cardiol; 2015; 187():651-7. PubMed ID: 25880403
[TBL] [Abstract][Full Text] [Related]
24. Blood Trimethylamine-N-Oxide Originates from Microbiota Mediated Breakdown of Phosphatidylcholine and Absorption from Small Intestine.
Stremmel W; Schmidt KV; Schuhmann V; Kratzer F; Garbade SF; Langhans CD; Fricker G; Okun JG
PLoS One; 2017; 12(1):e0170742. PubMed ID: 28129384
[TBL] [Abstract][Full Text] [Related]
25. Serum gut microbe-dependent trimethylamine N-oxide improves the prediction of future cardiovascular disease in a community-based general population.
Zheng L; Zheng J; Xie Y; Li Z; Guo X; Sun G; Sun Z; Xing F; Sun Y
Atherosclerosis; 2019 Jan; 280():126-131. PubMed ID: 30508691
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
[TBL] [Abstract][Full Text] [Related]
27. Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome.
Eyupoglu ND; Caliskan Guzelce E; Acikgoz A; Uyanik E; Bjørndal B; Berge RK; Svardal A; Yildiz BO
Clin Endocrinol (Oxf); 2019 Dec; 91(6):810-815. PubMed ID: 31556132
[TBL] [Abstract][Full Text] [Related]
28. Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.
Haissman JM; Haugaard AK; Ostrowski SR; Berge RK; Hov JR; Trøseid M; Nielsen SD
BMC Infect Dis; 2017 Jun; 17(1):445. PubMed ID: 28645263
[TBL] [Abstract][Full Text] [Related]
29. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Wang Z; Klipfell E; Bennett BJ; Koeth R; Levison BS; Dugar B; Feldstein AE; Britt EB; Fu X; Chung YM; Wu Y; Schauer P; Smith JD; Allayee H; Tang WH; DiDonato JA; Lusis AJ; Hazen SL
Nature; 2011 Apr; 472(7341):57-63. PubMed ID: 21475195
[TBL] [Abstract][Full Text] [Related]
30. Dysbiosis of Gut Microbiota With Reduced Trimethylamine-N-Oxide Level in Patients With Large-Artery Atherosclerotic Stroke or Transient Ischemic Attack.
Yin J; Liao SX; He Y; Wang S; Xia GH; Liu FT; Zhu JJ; You C; Chen Q; Zhou L; Pan SY; Zhou HW
J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26597155
[TBL] [Abstract][Full Text] [Related]
31. High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study.
Whelton SP; McEvoy JW; Lazo M; Coresh J; Ballantyne CM; Selvin E
Diabetes Care; 2017 Feb; 40(2):261-269. PubMed ID: 28108537
[TBL] [Abstract][Full Text] [Related]
32. A Multi-omic Association Study of Trimethylamine N-Oxide.
Manor O; Zubair N; Conomos MP; Xu X; Rohwer JE; Krafft CE; Lovejoy JC; Magis AT
Cell Rep; 2018 Jul; 24(4):935-946. PubMed ID: 30044989
[TBL] [Abstract][Full Text] [Related]
33. [Impact of L-carnitine and phosphatidylcholine containing products on the proatherogenic metabolite TMAO production and gut microbiome changes in patients with coronary artery disease].
Ivashkin VT; Kashukh YA
Vopr Pitan; 2019; 88(4):25-33. PubMed ID: 31722138
[No Abstract] [Full Text] [Related]
34. Trimethylamine N-Oxide, a Gut Microbiota-Dependent Metabolite, is Associated with Frailty in Older Adults with Cardiovascular Disease.
He W; Luo Y; Liu JP; Sun N; Guo D; Cui LL; Zheng PP; Yao SM; Yang JF; Wang H
Clin Interv Aging; 2020; 15():1809-1820. PubMed ID: 33061331
[TBL] [Abstract][Full Text] [Related]
35. Gut microbial metabolite TMAO portends prognosis in acute ischemic stroke.
Zhang J; Wang L; Cai J; Lei A; Liu C; Lin R; Jia L; Fu Y
J Neuroimmunol; 2021 May; 354():577526. PubMed ID: 33647820
[TBL] [Abstract][Full Text] [Related]
36. Plasma Trimethylamine N-Oxide as a Novel Biomarker for Plaque Rupture in Patients With ST-Segment-Elevation Myocardial Infarction.
Tan Y; Sheng Z; Zhou P; Liu C; Zhao H; Song L; Li J; Zhou J; Chen Y; Wang L; Qian H; Sun Z; Qiao S; Xu B; Gao R; Yan H
Circ Cardiovasc Interv; 2019 Jan; 12(1):e007281. PubMed ID: 30599768
[TBL] [Abstract][Full Text] [Related]
37. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
38. Trimethylamine N-oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction.
Zhou X; Jin M; Liu L; Yu Z; Lu X; Zhang H
ESC Heart Fail; 2020 Feb; 7(1):188-193. PubMed ID: 31960610
[TBL] [Abstract][Full Text] [Related]
39. Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.
Senthong V; Wang Z; Li XS; Fan Y; Wu Y; Tang WH; Hazen SL
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27287696
[TBL] [Abstract][Full Text] [Related]
40. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
Winther SA; Øllgaard JC; Tofte N; Tarnow L; Wang Z; Ahluwalia TS; Jorsal A; Theilade S; Parving HH; Hansen TW; Hazen SL; Pedersen O; Rossing P
Diabetes Care; 2019 Aug; 42(8):1512-1520. PubMed ID: 31123156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
